ArticleBMC pharmacology & toxicology2025
A real-world pharmacovigilance study of netarsudil based on the FDA adverse event reporting system (FAERS).
Xiaomei Xiong et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it